Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Osteoporosis Reports
Published in: Current Osteoporosis Reports 4/2011

01-12-2011 | Epidemiology and Pathophysiology (Mone Zaidi and Jeffrey I. Mechanick, Section Editors)

Nutrition, Bone, and Aging: An Integrative Physiology Approach

Authors: Rifka C. Schulman, Aaron J. Weiss, Jeffrey I. Mechanick

Published in: Current Osteoporosis Reports | Issue 4/2011

Login to get access

Abstract

Osteoporosis, a condition associated with significant morbidity and mortality, is prevalent in the growing elderly population. Aging is associated with characteristic changes in the complex pathways of bone remodeling and in patterns of food intake. Whereas the traditional focus of nutritional supplementation for protection of bone health has centered around calcium and vitamin D, a multitude of nutrients have been identified with effects on bone, both individually and in combination. An integrative physiology approach can assist in formulating a deeper understanding of the complex interactions of nutrition and aging with bone, with the goal of identifying modifiable risk factors for the prevention of bone loss.
Literature
1.
Palacios C. The role of nutrients in bone health, from A to Z. Crit Rev Food Sci Nutr. 2006;46:621–8.PubMedCrossRef
2.
3.
Dennehy C, Tsourounis C. A review of select vitamins and minerals used by postmenopausal women. Maturitas. 2010;66:370–80.PubMedCrossRef
4.
Body JJ, Bergmann P, Boonen S, et al. Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club. Osteoporos Int. 2011 Mar 1 (epub ahead of print).
5.
Weiss AJ, Iqbal J, Zaidi N, et al. The skeletal subsystem as an integrative physiology paradigm. Curr Osteoporos Rep. 2010;8:168–77.PubMedCrossRef
6.
Heino TJ, Hentunen TA, Vaananen HK. Osteocytes inhibit osteoclastic bone resorption through transforming growth factor-beta: enhancement by estrogen. J Cell Biochem. 2002;85:185–97.PubMedCrossRef
7.
Raggatt LJ, Partridge NC. Cellular and molecular mechanisms of bone remodeling. J Biol Chem. 2010;285:25103–8.PubMedCrossRef
8.
Nakagawa N, Kinosaki M, Yamaguchi K, et al. RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun. 1998;253:395–400.PubMedCrossRef
9.
Lorenzo JA, Canalis E, Raisz LG. Metabolic bone disease. In: Kronenberg HM et al., editors. Williams textbook of endocrinology. Philadelphia: Saunders Elsevier; 2008. p. 1269–310.
10.
Yasuda H, Shima N, Nakagawa N, et al. A novel molecular mechanism modulating osteoclast differentiation and function. Bone. 1999;25:109–13.PubMedCrossRef
11.
Tang Y, Wu X, Lei W, et al. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med. 2009;15:757–65.PubMedCrossRef
12.
Maggio D, Barabani M, Pierandrei M, et al. Marked decrease in plasma antioxidants in aged osteoporotic women: results of a cross-sectional study. JCEM. 2003;88:1523–7.PubMed
13.
14.
Manolagas SC, Parfitt AM. What old means to bone. Trends Endocrinol Metabol. 2010;21:369–74.CrossRef
15.
Shen CL, Yeh JK, Cao JJ, et al. Green tea and bone health: evidence from laboratory studies. Pharmacol Res. 2011;64:155–161.
16.
Shaw AC, Joshi S, Greenwood H, et al. Aging of the innate immune system. Curr Opin Immunol. 2010;22:507–13.PubMedCrossRef
17.
Weitzmann MN, Pacifici R. T cells: unexpected players in the bone loss induced by estrogen deficiency and in basal bone homeostasis. Ann NY Acad Sci. 2007;1116:360–75.PubMedCrossRef
18.
19.
McKane WR, Khosla S, Burritt MF, et al. Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmeopause—a clinical research center study. J Clin Endocrinol Metab. 1995;80:3458–64.PubMedCrossRef
20.
Frost HM. On our age-related bone loss: insights from a new paradigm. J Bone Miner Res. 1997;12:1539–46.PubMedCrossRef
21.
Melton III JLM, Riggs BL, Achenbach SJ, et al. Does reduced skeletal loading account for age-related bone loss. J Bone Miner Res. 2006;21:1847–55.PubMedCrossRef
22.
23.
Ahmed T, Haboubi N. Assessment and management of nutrition in older people and its importance to health. Clin Interv Aging. 2010;5:207–16.PubMed
24.
Di Francesco V, Zamboni M, Dioli A, et al. Delayed postprandial gastric emptying and impaired gallbladder contraction together with elevated cholecystokinin and peptide YY serum levels sustain satiety and inhibit hunger in healthy elderly persons. J Gerontol. 2005;60A:1581–5.
25.
Yeh SS, Schuster MW. Geriatric cachexia: the role of cytokines. Am J Clin Nutr. 1999;70:183–97.PubMed
26.
Fralic J, Griffin C. Nutrition and the elderly: a case manager’s guide. Lippincotts Case Manag. 2001;6:177–8.PubMedCrossRef
27.
Ross AC, Taylor CL, Yaktine AL, et al. Dietary reference intakes for calcium and vitamin D. Institute of Medicine, National Academy of Sciences, 2010.
28.
Shea B, Wells G, Cranney A, et al. Calcium supplementation on bone loss in postmenopausal women. Cochrane Database Syst Rev. 2004;1:CD004526.PubMed
29.
Tang BMP, Eslick GD, Nowson C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet. 2007;370:657–66.PubMedCrossRef
30.
Rabenda V, Bruyere O, Reginster JY. Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression. Osteoporos Int. 2011;22:893–901.PubMedCrossRef
31.
Bischoff-Ferrari HA, Dawson-Hughes B, Baron JA, et al. Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr. 2007;86:1780–90.PubMed
32.
Reid IR, Bolland MJ, Grey A. Effect of calcium supplementation on hip fractures. Osteoporos Int. 2008;19:1119–23.PubMedCrossRef
33.
Tang BMP. Does calcium supplementation really cause more hip fractures? Osteoporos Int. 2009;20:833–4.PubMedCrossRef
34.
Heaney RP, Nordin BE. Calcium effects on phosphorous absorption: implications for the prevention and co-therapy of osteoporosis. J Am Coll Nutr. 2002;21:239–44.PubMed
35.
•• Bolland MJ, Avenell A, Baron JA. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ. 2010;341:c3691. This meta-analysis publicized the concern for increased cardiovascular events with calcium supplementation. PubMedCrossRef
36.
Lanham-New SA. The balance of bone health: tipping the scales in favor of potassium-rich, bicarbonate-rich foods. J Nutr. 2008;138:172s–7s.PubMed
37.
Meghji S, Morrison MS, Henderson B, et al. pH dependence of bone resorption: mouse calvarial osteoclasts are activated by acidosis. Am J Physiol Endocrinol Metab. 2001;280:E112–9.PubMed
38.
Lemann Jr J, Pleuss JA, Gray RW. Potassium causes calcium retention in healthy adults. J Nutr. 1993;123:1623–6.PubMed
39.
Buclin T, Cosma M, Appenzeller M, et al. Diet acids and alkalis influence calcium retention in bone. Osteoporos Int. 2001;12:493–9.PubMedCrossRef
40.
Macdonald HM, New SA, Fraser WD, et al. Low dietary potassium intakes and high dietary estimates of NEAP are associated with low BMD in premenopausal women and increased markers of bone resorption in postmenopausal women. Am J Clin Nutr. 2005;81:923–33.PubMed
41.
Zhu K, Devine A, Prince RL. The effects of high potassium consumption on bone mineral density in a prospective cohort study of elderly postmenopausal women. Osteoporos Int. 2009;20:335–40.PubMedCrossRef
42.
Macdonald HM, Black AJ, Aucott L, et al. Effect of potassium citrate supplementation or increased fruit and vegetable intake on bone metabolism in healthy postmenopausal women: a randomized controlled trial. Am J Clin Nutr. 2008;88:465–74.PubMed
43.
•• Fenton TR, Tough SC, Lyon AW, et al. Causal assessment of dietary acid load and bone disease: a systematic review and meta-analysis applying Hill’s epidemiologic criteria for causality. Nutr J. 2011;10:41 (epub ahead of print). This recent meta-analysis calls in to question the validity of the acid-base theory of diet relating to bone. PubMedCrossRef
44.
Odabasi E, Turan M, Aydin A, et al. Magnesium, zinc, copper, manganese and selenium levels in postmenopausal women with osteoporosis. Can magnesium play a key role in osteoporosis? Ann Acad Med Singapore. 2008;37:564–7.PubMed
45.
Rude RK, Gruber HE. Magnesium deficiency and osteoporosis: animal and human observations. J Nutr Biochem. 2004;15:710–6.PubMedCrossRef
46.
Aydin H, Deyneli O, Yavuz D, et al. Short-term oral magnesium supplementation suppresses bone turnover in postmenopausal osteoporotic women. Biol Trace Elem Res. 2010;133:136–43.PubMedCrossRef
47.
Teucher B, Dainty JR, Spinks CA, et al. Sodium and bone health: Impact of moderately high and low salt intakes on calcium metabolism in postmenopausal women. J Bone Miner Res. 2008;23:1477–85.PubMedCrossRef
48.
Devine A, Criddle RA, Dick IM, et al. A longitudinal study of the effect of sodium and calcium intakes on regional bone density in postmenopausal women. Am J Clin Nutr. 1995;62:740–5.PubMed
49.
Kurland ES, Schulman RC, Zerwekh JE, et al. Recovery from skeletal fluorosis (an enigmatic, American case). J Bone Miner Res. 2007;22:163–70.PubMedCrossRef
50.
51.
Perez-Lopez FR, Chedraui P, Fernandez-Alonso AM. Vitamin D and aging: beyond calcium and bone metabolism. Maturitas. 2011;69:27–36.PubMedCrossRef
52.
Kalyani RR, Stein B, Valiyil R, et al. Vitamin D treatment for the prevention of falls in older people in nursing care facilities and hospitals. Cochrane Database Syst Rev. 2010;(1):CD005465.
53.
Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. JCEM. 2011, June, epub ahead of print.
54.
Dipart (vitamin D Individual Patient Analysis of Randomized Trials) Group. Patient level pooled analysis of 68,500 patients from seven major vitamin D fracture trials in US and Europe. BMJ. 2010;340:b5463.CrossRef
55.
•• Avenell A, Gillespie WJ, Gillespie LD, et al. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2009;2:CD000227. This Cochrane review extensively analyzes the association of vitamin D with fracture prevention. PubMed
56.
The WHO Scientific Group. Prevention and management of osteoporosis. World Health Organ Tech Rep Ser. 2003;921:86–109.
57.
Iwamoto J, Sato Y, Takeda T, et al. High-dose vitamin K supplementation reduces fracture incidence in postmenopausal women: a review of the literature. Nutr Res. 2009;29:221–8.PubMedCrossRef
58.
Tab MM, Sun A, Zhou C, et al. Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem. 2003;278:43919–27.CrossRef
59.
Shiraki M, Shiraki Y, Aoki C, et al. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res. 2000;15:515–21.PubMedCrossRef
60.
Cheung AM, Tile L, Lee Y, et al. Vitamin K supplementation in postmenopausal women with osteopenia (ECKO trial): a randomized controlled trial. PLos Med. 2008;5:e196.PubMedCrossRef
61.
Inoue T, Fujita T, Kishimoto H, et al. Randomized controlled study on the prevention of osteoporotic fractures (OF study): a phase IV clinical study of 15-mg menatetrenone capsules. J Bone Miner Metabol. 2009;27:66–75.CrossRef
62.
Basu S, Michaelsson K, Olofsson H, et al. Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun. 2001;288:275–9.PubMedCrossRef
63.
Sahni S, Hannan MT, Gagnon D, et al. High vitamin C intake is associated with lower 4-year bone loss in elderly men. J Nutr. 2008;138:1931–8.PubMed
64.
Melhus H, Michaelsson K, Holmberg L, et al. Smoking, antioxidant vitamins, and the risk of hip fracture. J Bone Miner Res. 1999;14:129–35.PubMedCrossRef
65.
Zhang J, Munger RG, West NA, et al. Antioxidant intake and risk of osteoporotic hip fracture in Utah: an effect modified by smoking status. Am J Epidemiol. 2006;163:9–17.PubMedCrossRef
66.
Ruiz-Ramos M, Vargas LA, Fortoul van der Goes TI, et al. Supplementation of ascorbic acid and alpha-tocopherol is useful to preventing bone loss linked to oxidative stress in elderly. J Nutr Health Aging. 2010;14:467–72.PubMedCrossRef
67.
McLean RR, Hannan MT. B vitamins, homocysteine, and bone disease: epidemiology and pathophysiology. Curr Osteoporos Rep. 2007;5:112–9.PubMedCrossRef
68.
Van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, et al. Homocysteine levels and the risk of osteoporotic fracture. NEJM. 2004;350:2033–41.PubMedCrossRef
69.
McLean RR, Jacques PF, Selhub J, et al. Homocysteine as a predictive factor for hip fractures in older persons. NEJM. 2004;350:2042–9.PubMedCrossRef
70.
Eastell R, Vieira NE, Yergey AL, et al. Pernicious anaemia as a risk factor for osteoporosis. Clin Sci (Lond). 1992;82:681–5.
71.
Sato Y, Honda Y, Iwamoto J, et al. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA. 2005;293:1082–8.PubMedCrossRef
72.
Herrmann M, Umanskaya N, Traber L, et al. The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial. Clin Chem Lab Med. 2007;45:1785–92.PubMedCrossRef
73.
Caire-Juvera G, Ritenbaugh C, Wactawski-Wende J, et al. Vitamin A and retinol intakes and the risk of fractures among participants of the Women’s Health Initiative Observational Study. Am J Clin Nutr. 2009;89:323–30.PubMedCrossRef
74.
Vestergaard P, Rejnmark L, Mosekilde L. High-dose treatment with vitamin A analogues and risk of fractures. Arch Dermatol. 2010;146:478–82.PubMedCrossRef
75.
Feskanich D, Singh V, Willett WC, et al. Vitamin A intake and hip fractures among postmenopausal women. JAMA. 2002;287:47–54.PubMedCrossRef
76.
Johansson S, Melhus H. Vitamin A antagonizes calcium response to vitamin D in man. J Bone Miner Res. 2001;16:1899–905.PubMedCrossRef
77.
Ribaya-Mercado JD, Blumberg JB. Vitamin A: is it a risk factor for osteoporosis and bone fracture? Nutr Rev. 2007;65:425–38.PubMedCrossRef
78.
Sahni S, Hannan MT, Blumberg J, et al. Protective effect of total carotenoid and lycopene intake on the risk of hip fracture: a 17-year follow-up from the Framingham Osteoporosis Study. J Bone Miner Res. 2009;24:1086–94.PubMedCrossRef
79.
Kerstetter JE, Kenny AM, Insogna KL. Dietary protein and skeletal health: a review of recent human research. Curr Opin Lipidol. 2011;22:16–20.PubMedCrossRef
80.
Kerstetter JE, O’Brien KO, Insogna KL. Dietary protein, calcium metabolism, and skeletal homeostasis revisited. Am J Clin Nutr. 2003;78:584s–92s.PubMed
81.
De Souza Genaro P, Martini LA. Effect of protein intake on bone and muscle mass in the elderly. Nutr Rev. 2010;68:616–23.CrossRef
82.
Schurch MA, Rizzoli R, Slosman D, et al. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. Ann Intern Med. 1998;128:801–9.PubMed
83.
•• Darling AL, Milward DJ, Torgerson DJ, et al. Dietary protein and bone health: a systematic review and meta-analysis. Am J Clin Nutr. 2009;90:1674–92. This is the first systematic review and meta-analysis studying the relationship of protein and bone. PubMedCrossRef
84.
Katz MG, Vollenhoven B. The reproductive endocrine consequences of anorexia nervosa. BJOG. 2000;107:707–13.PubMedCrossRef
85.
Usdan LS, Khaodhiar L, Apovian CM. The endocrinopathies of anorexia nervosa. Endocr Pract. 2008;14:1055–63.PubMed
86.
Caporaso F, Frisch F, Sumida KD. Compromised bone health in non-obese, older women with low caloric intake. J Community Health. 2011;36:559–64.PubMedCrossRef
87.
Yoo HJ, Park MS, Yang SJ, et al. The differential relationship between fat mass and bone mineral density by gender and menopausal status. J Bone Miner Metabol. 2011. doi:10.​1007/​s00774-011-0283-7.
88.
Orchard TS, Cauley JA, Frank GC, et al. Fatty acid consumption and risk of fracture in the Women’s Health Initiative. Am J Clin Nutr. 2010;92:1452–60.PubMedCrossRef
89.
Bawa S. The significance of soy protein and soy bioactive compounds in the prophylaxis and treatment of osteoporosis. J Osteoporos. 2010:891058.
90.
Lauderdale DS, Jacobsen SJ, Furner SE, et al. Hip fracture incidence among elderly Asian-American populations. Am J Epidemiol. 1997;146:502–9.PubMed
91.
Miadokova E. Isoflavonoids—an overview of their biological activities and potential health benefits. Interdiscipl Toxicol. 2009;2:211–8.CrossRef
92.
Taku K, Melby MK, Takebayashi J, et al. Effect of soy isoflavone extract supplements on bone mineral density in menopausal women: meta-analysis of randomized controlled trials. Asia Pac J Clin Nutr. 2010;19:33–42.PubMed
93.
Berg KM, Kunins HV, Jackson JL, et al. Association between alcohol consumption and both osteoporotic fracture and bone density. Am J Med. 2008;121:406–18.PubMedCrossRef
94.
Gavaler JS, Van Thiel DH. The association between moderate alcoholic beverage consumption and serum estradiol and testosterone levels in normal post-menopausal women: relationship to the literature. Alcohol Clin Exp Res. 1992;16:87.PubMedCrossRef
95.
Rayalam S, Della-Fera MA, Baile CA. Synergism between resveratrol and other phytochemicals: implications for obesity and osteoporosis. Mol Nutr Food Res. 2011;55:1–9.CrossRef
96.
Zhou Y, Zhu Z, Guan X, et al. Reciprocal roles between caffeine and estrogen on bone via differently regulating cAMP/PKA pathway: the possible mechanism for caffeine-induced osteoporosis in women and estrogen’s antagonistic effects. Med Hypothesis. 2009;73:83–5.CrossRef
97.
Kiel DP, Felson DT, Hannan MT, et al. Caffeine and the risk of hip fracture: the Framingham Study. Am J Epidemiol. 1990;132:675–84.PubMed
98.
Tucker KL, Morita K, Qiao N, et al. Colas, but not other carbonated beverages, are associated with low bone mineral density in older women: the Framingham Osteoporosis Study. Am J Clin Nutr. 2006;84:936–42.PubMed
99.
100.
Hallanger Johnson JE, Kearns AE, Doran M, et al. Fluoride-related bone disease associated with habitual tea consumption. Mayo Clin Proc. 2007;82:719–24.PubMedCrossRef
101.
Weiss AJ, Lipshtat A, Mechanick JI. A systems approach to bone pathophysiology. Ann NY Acad Sci. 2010;1211:9–24.PubMedCrossRef
Metadata
Title
Nutrition, Bone, and Aging: An Integrative Physiology Approach
Authors
Rifka C. Schulman
Aaron J. Weiss
Jeffrey I. Mechanick
Publication date
01-12-2011
Publisher
Current Science Inc.
Published in
Current Osteoporosis Reports / Issue 4/2011
Print ISSN: 1544-1873
Electronic ISSN: 1544-2241
DOI
https://doi.org/10.1007/s11914-011-0079-7

Other articles of this Issue 4/2011

Current Osteoporosis Reports 4/2011 Go to the issue

Epidemiology and Pathophysiology (Mone Zaidi and Jeffrey I. Mechanick, Section Editors)

Vitamin D in the Persian Gulf: Integrative Physiology and Socioeconomic Factors

Pediatrics and Skeletal Development (Craig Langman and Maria Luisa Bianchi, Section Editors)

Rickets

Epidemiology and Pathophysiology (Mone Zaidi and Jeffrey I. Mechanick, Section Editors)

Stem Cell Interactions in a Bone Marrow Niche

Pediatrics and Skeletal Development (Craig Langman and Maria Luisa Bianchi, Section Editors)

Quantitative Computed Tomography and Computed Tomography in Children

Epidemiology and Pathophysiology (Mone Zaidi and Jeffrey I. Mechanick, Section Editors)

Microarchitectural Changes in the Aging Skeleton

Epidemiology and Pathophysiology (Mone Zaidi and Jeffrey I. Mechanick, Section Editors)

The Effects of Smoke Carcinogens on Bone